Basal ganglia dopamine depletion does not alter D1 dopamine receptor binding properties.
Trugman
J M
JM
Department of Neurology, University of Virginia Medical Center, Charlottesville 22908.
Pronsky
C J
CJ
Wooten
G F
GF
D000818:Animals; D001345:Autoradiography; D001479:Basal Ganglia / Q000187:drug effects*; D001552:Benzazepines / Q000493:pharmacokinetics*; D003342:Corpus Striatum / Q000187:drug effects; D004298:Dopamine / Q000502:physiology*; D018492:Dopamine Antagonists; D006892:Hydroxydopamines / Q000494:pharmacology*; D008297:Male; D009434:Neural Pathways / Q000187:drug effects; D016627:Oxidopamine; D051381:Rats; D011919:Rats, Inbred Strains; D011954:Receptors, Dopamine / Q000187:drug effects*; D017447:Receptors, Dopamine D1; D013378:Substantia Nigra / Q000187:drug effects
D001552:Benzazepines; D018492:Dopamine Antagonists; D006892:Hydroxydopamines; D011954:Receptors, Dopamine; D017447:Receptors, Dopamine D1; D016627:Oxidopamine; D004298:Dopamine